Diuretic use and the risk of breast cancer

Journal of Human Hypertension

Volumn 23, Issue 3, 2009, Pages 216-218

  Coogan, P F ^a   Strom, B L ^b   Rosenberg, L ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; CHLORTALIDONE; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ADULT; AGE DISTRIBUTION; AGED; ARTHRITIS; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; DRUG CLASSIFICATION; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFECTION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MELANOMA; MUSCULOSKELETAL DISEASE; PATIENT INFORMATION; PATIENT PARTICIPATION; POPULATION RESEARCH; QUESTIONNAIRE; SIDE EFFECT; SKIN CANCER; SKIN DISEASE; THYROID DISEASE; UNITED STATES;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIURETICS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 60549088273     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.131     Document Type: Article

References (12)

1. Grossman E, Messerli FH, Goldbourt U. Antihypertensive therapy and the risk of malignancies. Eur Heart J 2001; 22: 1343-1352.
2. Felmeden DC, Lip GY. Antihypertensive therapy and cancer risk. Drug Saf 2001; 24: 727-739.
3. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002; 287: 337-344.
4. Sarafidis PA, McFarlane SI, Bakris GL. Antihypertensive agents, insulin sensitivity, and new-onset diabetes. Curr Diab Rep 2007; 7: 191-199.
5. Eriksson JW, Fowelin J, Urbanavicius V. Insulin concentrations and insulin sensitivity after short-term amiloride in healthy subjects. Eur J Clin Pharmacol 1994; 46: 469-472.
6. Falch DK, Schreiner A. The effect of spironolactone on lipid, glucose and uric acid levels in blood during long-term administration to hypertensives. Acta Med Scand 1983; 213: 27-30.
7. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6: 103-111.
8. Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997; 80: 1438-1447.
9. Gonzalez-Perez A, Ronquist G, Garcia Rodriguez LA. Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf 2004; 13: 581-585.
10. Fryzek JP, Poulsen AH, Lipworth L, Pedersen L, Norgaard M, McLaughlin JK et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat 2006; 97: 231-236.
11. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N et al Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006; 20: 727-732.
12. Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer 2003; 98: 1504-1513.